In patients given postmastectomy radiotherapy (PMRT), the chest wall is a very thin layer of soft tissue with a low-density lung tissue behind. Chest wall treated in this situation with a high-energy photon beam presents a high dosimetric uncertainty region for both calculation and measurement. The ...
In patients given postmastectomy radiotherapy (PMRT), the chest wall is a very thin layer of soft tissue with a low-density lung tissue behind. Chest wall treated in this situation with a high-energy photon beam presents a high dosimetric uncertainty region for both calculation and measurement. The purpose of this study was to measure and to evaluate the surface and superficial doses for patients requiring PMRT with different treatment techniques. An elliptic cylinder cork and superflab boluses were used to simulate the lung and the chest wall, respectively. Sets of computed tomography (CT) images with different chest wall thicknesses were acquired for the study phantom. Hypothetical clinical target volumes (CTVs) were outlined and modified to fit a margin of 1-3 mm, depending on the chest wall thickness, away from the surface for the sets of CT images. The planning target volume (PTV) was initially created by expanding an isotropic 3-mm margin from the CTV, and then a margin of 3 mm was shrunk from the phantom surface to avoid artifact-driven results in the beam-let intensity. Treatment techniques using a pair of tangential wedged fields (TWFs) and 4-field intensity-modulated radiation therapy (IMRT) were designed with a prescribed fraction dose (Dp) of 180 cGy. Superficial dose profiles around the phantom circumference at depths of 0, 1, 2, 3, and 5 mm were obtained for each treatment technique using radiochromic external beam therapy (EBT) films. EBT film exhibits good characteristics for dose measurements in the buildup region. Underdoses at the median and lateral regions of the TWF plans were shown. The dose profiles at shallow depths for the TWF plans show a dose buildup about 3 mm at the median and lateral tangential incident regions with a surface dose of about 52% of Dp. The dose was gradually increased toward the most obliquely tangential angle with a maximum dose of about 118% of Dp. Dose profiles were more uniform in the PTV region for the 4-F IMRT plans. Most of the PTV region had doses >94% of Dp at depths >1 mm. The mean surface dose was about 65% of Dp for the 4-F IMRT plans. The maximum dose for the 4-F IMRT plans was <118.4% of Dp. The application of added bolus has to consider the treatment technique, tumor coverage, and possible skin reactions. For PMRT, if the chest surface and wall are treated adequately, at least 3 mm bolus should be added to the chest wall when tangential beams and 6-MV photon energy are arranged. However, when the surface and superficial regions are not high-risk areas, an IMRT plan with tangential beams and 6-MV photon energy can provide uniform dose distributions within the PTV, spare the skin reaction, and deliver sufficient doses to the chest wall at depths >1 mm.
In patients given postmastectomy radiotherapy (PMRT), the chest wall is a very thin layer of soft tissue with a low-density lung tissue behind. Chest wall treated in this situation with a high-energy photon beam presents a high dosimetric uncertainty region for both calculation and measurement. The purpose of this study was to measure and to evaluate the surface and superficial doses for patients requiring PMRT with different treatment techniques. An elliptic cylinder cork and superflab boluses were used to simulate the lung and the chest wall, respectively. Sets of computed tomography (CT) images with different chest wall thicknesses were acquired for the study phantom. Hypothetical clinical target volumes (CTVs) were outlined and modified to fit a margin of 1-3 mm, depending on the chest wall thickness, away from the surface for the sets of CT images. The planning target volume (PTV) was initially created by expanding an isotropic 3-mm margin from the CTV, and then a margin of 3 mm was shrunk from the phantom surface to avoid artifact-driven results in the beam-let intensity. Treatment techniques using a pair of tangential wedged fields (TWFs) and 4-field intensity-modulated radiation therapy (IMRT) were designed with a prescribed fraction dose (Dp) of 180 cGy. Superficial dose profiles around the phantom circumference at depths of 0, 1, 2, 3, and 5 mm were obtained for each treatment technique using radiochromic external beam therapy (EBT) films. EBT film exhibits good characteristics for dose measurements in the buildup region. Underdoses at the median and lateral regions of the TWF plans were shown. The dose profiles at shallow depths for the TWF plans show a dose buildup about 3 mm at the median and lateral tangential incident regions with a surface dose of about 52% of Dp. The dose was gradually increased toward the most obliquely tangential angle with a maximum dose of about 118% of Dp. Dose profiles were more uniform in the PTV region for the 4-F IMRT plans. Most of the PTV region had doses >94% of Dp at depths >1 mm. The mean surface dose was about 65% of Dp for the 4-F IMRT plans. The maximum dose for the 4-F IMRT plans was <118.4% of Dp. The application of added bolus has to consider the treatment technique, tumor coverage, and possible skin reactions. For PMRT, if the chest surface and wall are treated adequately, at least 3 mm bolus should be added to the chest wall when tangential beams and 6-MV photon energy are arranged. However, when the surface and superficial regions are not high-risk areas, an IMRT plan with tangential beams and 6-MV photon energy can provide uniform dose distributions within the PTV, spare the skin reaction, and deliver sufficient doses to the chest wall at depths >1 mm.
N. Engl. J. Med. Overgaard 337 949 1997 10.1056/NEJM199710023371401 Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
N. Engl. J. Med. Ragaz 337 956 1997 10.1056/NEJM199710023371402 Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
Lancet Overgaard 353 1641 1999 10.1016/S0140-6736(98)09201-0 Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
J. Clin. Oncol. Recht 19 1539 2001 10.1200/JCO.2001.19.5.1539 Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology
Uschold 843 2004 Principles and practice of radiation therapy Breast cancer
Clin. Oncol. Vu 19 115 2007 10.1016/j.clon.2006.10.004 Variability in radiation oncologists' opinion on the indication of a bolus in post-mastectomy radiotherapy: An International survey
Int. J. Radiat. Oncol. Biol. Phys. Beckham 69 918 2007 10.1016/j.ijrobp.2007.06.060 Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?
Int. J. Radiat. Oncol. Biol. Phys. Hong 44 1155 1999 10.1016/S0360-3016(99)00132-7 Intensity-modulated tangential beam irradiation of the intact breast
Int. J. Radiat. Oncol. Biol. Phys. Krueger 56 1023 2003 10.1016/S0360-3016(03)00183-4 Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy
Int. J. Radiat. Oncol. Biol. Phys. Remouchamps 55 392 2003 10.1016/S0360-3016(02)04143-3 Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation
Int. J. Radiat. Oncol. Biol. Phys. Saibishkumar 70 485 2008 10.1016/j.ijrobp.2007.06.049 Skin-sparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: A planning study
Radiother. Oncol. Evans 57 79 2000 10.1016/S0167-8140(00)00263-2 The delivery of intensity modulated radiotherapy to the breast using multiple static fields
Med. Phys. Chiu-Tsao 32 3350 2005 10.1118/1.2065467 Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies
Med. Phys. Ezzell 30 2089 2003 10.1118/1.1591194 Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee
Med. Phys. Shiau 38 1435 2011 10.1118/1.3553406 Dosimetric verification of surface and superficial doses for head and neck IMRT with different PTV shrinkage margins
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.